CANSINO BIOLOGICS INC revenue breakdown overview

CANSINO BIOLOGICS INC revenue for the last year amounted to 112.98 M USD, the most of which — 111.66 M USD — came from its highest performing source at the moment, Vaccine and Related Products. The greatest contribution to the revenue figure was made by China — last year it brought CANSINO BIOLOGICS INC 110.94 M USD, and the year before that — 48.39 M USD.